edoc

Items where contributor is "Manjaly Thomas, Zita-Rose"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2019 | 2018 | 2016 | 2015 | 2014

2019

Manjaly Thomas, Zita-Rose and Hartmann, Karin. (2019) Skin Disease in Mastocytosis. In: Mastocytosis. A Comprehensive Guide. Cham, pp. 69-91.

Schmid, Yasmin and Navarini, Alexander and Manjaly Thomas, Zita-Rose and Pfleiderer, Bettina and Krähenbühl, Stephan and Mueller, Simon M.. (2019) Sex differences in the pharmacology of itch therapies - a narrative review. Current Opinion in Pharmacology, 46. pp. 122-142.

Manjaly Thomas, Zita-Rose and Satti, Iman and Marshall, Julia L. and Harris, Stephanie A. and Lopez Ramon, Raquel and Hamidi, Ali and Minhinnick, Alice and Riste, Michael and Stockdale, Lisa and Lawrie, Alison M. and Vermaak, Samantha and Wilkie, Morven and Bettinson, Henry and McShane, Helen. (2019) Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial. PLoS Medicine, 16 (4). e1002790.

Müller, Julius and Tanner, Rachel and Matsumiya, Magali and Snowden, Margaret A. and Landry, Bernard and Satti, Iman and Harris, Stephanie A. and O'Shea, Matthew K. and Stockdale, Lisa and Marsay, Leanne and Chomka, Agnieszka and Harrington-Kandt, Rachel and Manjaly Thomas, Zita-Rose and Naranbhai, Vivek and Stylianou, Elena and Mbandi, Stanley Kimbung and Hatherill, Mark and Hussey, Gregory and Mahomed, Hassan and Tameris, Michele and McClain, J. Bruce and Evans, Thomas G. and Hanekom, Willem A. and Scriba, Thomas J. and McShane, Helen and Fletcher, Helen A.. (2019) Cytomegalovirus infection is a risk factor for tuberculosis disease in infants. JCI insight, 4 (23). e130090.

Wilkie, Morven and Satti, Iman and Minhinnick, Alice and Harris, Stephanie and Riste, Michael and Ramon, Raquel Lopez and Sheehan, Sharon and Manjaly Thomas, Zita-Rose and Wright, Daniel and Stockdale, Lisa and Hamidi, Ali and O'Shea, Matthew K. and Dwivedi, Kritica and Behrens, Hannah Michaela and Davenne, Tamara and Morton, Joshua and Vermaak, Samantha and Lawrie, Alison and Moss, Paul and McShane, Helen. (2019) A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults. Vaccine, 38 (4). pp. 779-789.

2018

Harris, Stephanie A. and White, Andrew and Stockdale, Lisa and Tanner, Rachel and Sibley, Laura and Sarfas, Charlotte and Meyer, Joel and Peter, Jonathan and O'Shea, Matthew K. and Manjaly Thomas, Zita-Rose and Hamidi, Ali and Satti, Iman and Dennis, Mike J. and McShane, Helen and Sharpe, Sally. (2018) Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines. Tuberculosis, 108. pp. 99-105.

2016

Fletcher, Helen A. and Snowden, Margaret A. and Landry, Bernard and Rida, Wasima and Satti, Iman and Harris, Stephanie A. and Matsumiya, Magali and Tanner, Rachel and O'Shea, Matthew K. and Dheenadhayalan, Veerabadran and Bogardus, Leah and Stockdale, Lisa and Marsay, Leanne and Chomka, Agnieszka and Harrington-Kandt, Rachel and Manjaly Thomas, Zita-Rose and Naranbhai, Vivek and Stylianou, Elena and Darboe, Fatoumatta and Penn-Nicholson, Adam and Nemes, Elisa and Hatherill, Mark and Hussey, Gregory and Mahomed, Hassan and Tameris, Michele and McClain, J. Bruce and Evans, Thomas G. and Hanekom, Willem A. and Scriba, Thomas J. and McShane, Helen. (2016) T-cell activation is an immune correlate of risk in BCG vaccinated infants. Nature Communications, 7. p. 11290.

Minhinnick, Alice and Satti, Iman and Harris, Stephanie and Wilkie, Morven and Sheehan, Sharon and Stockdale, Lisa and Manjaly Thomas, Zita-Rose and Lopez-Ramon, Raquel and Poulton, Ian and Lawrie, Alison and Vermaak, Samantha and Le Vert, Alexandre and Del Campo, Judith and Hill, Fergal and Moss, Paul and McShane, Helen. (2016) A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults. Vaccine, 34 (11). pp. 1412-1421.

2015

Al-Chalabi, Ammar and Manjaly Thomas, Zita-Rose and Norwood, Fiona and Scott, Kirsten. (2015) Clinical case studies in neurology: approaches to common neurological problems from King's College Hospital. London.

Manjaly Thomas, Zita-Rose and McShane, Helen. (2015) Aerosol immunisation for TB: matching route of vaccination to route of infection. Transactions of the Royal Society of Tropical Medicine and Hygiene, 109 (3). pp. 175-181.

Sheehan, Sharon and Harris, Stephanie A. and Satti, Iman and Hokey, David A. and Dheenadhayalan, Veerabadran and Stockdale, Lisa and Manjaly Thomas, Zita-Rose and Minhinnick, Alice and Wilkie, Morven and Vermaak, Samantha and Meyer, Joel and O'Shea, Matthew K. and Pau, Maria Grazia and Versteege, Isabella and Douoguih, Macaya and Hendriks, Jenny and Sadoff, Jerald and Landry, Bernard and Moss, Paul and McShane, Helen. (2015) A phase I, open-label trial, evaluating the safety and immunogenicity of candidate tuberculosis vaccines AERAS-402 and MVA85A, administered by prime-boost regime in BCG-vaccinated healthy adults. PloS One, 10 (11). e0141687.

2014

Harris, Stephanie A. and Satti, Iman and Matsumiya, Magali and Stockdale, Lisa and Chomka, Agnieszka and Tanner, Rachel and O'Shea, Matthew K. and Manjaly Thomas, Zita-Rose and Tameris, Michele and Mahomed, Hassan and Scriba, Thomas J. and Hanekom, Willem A. and Fletcher, Helen A. and McShane, Helen. (2014) Process of assay selection and optimization for the study of case and control samples from a phase IIb efficacy trial of a candidate tuberculosis vaccine, MVA85A. Clinical and vaccine immunology, 21 (7). pp. 1005-1011.

Satti, Iman and Meyer, Joel and Harris, Stephanie A. and Manjaly Thomas, Zita-Rose and Griffiths, Kristin and Antrobus, Richard D. and Rowland, Rosalind and Ramon, Raquel Lopez and Smith, Mary and Sheehan, Sharon and Bettinson, Henry and McShane, Helen. (2014) Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial. Lancet Infectious Diseases, 14 (10). pp. 939-946.